Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy
Lung cancer was demonstrated to be the most lethal type of malignant tumor amongst humans in the global cancer statistics of 2012. As one of the primary treatments, radiotherapy has been reported to induce remission in, and even cure, patients with lung cancer. However, the side effects of radiother...
Gespeichert in:
| Veröffentlicht in: | Oncology letters 2017-11, Vol.14 (5), p.5681-5687 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 5687 |
|---|---|
| container_issue | 5 |
| container_start_page | 5681 |
| container_title | Oncology letters |
| container_volume | 14 |
| creator | Lu, Zhonghua Tang, Yiting Luo, Judong Zhang, Shuyu Zhou, Xifa Fu, Lei |
| description | Lung cancer was demonstrated to be the most lethal type of malignant tumor amongst humans in the global cancer statistics of 2012. As one of the primary treatments, radiotherapy has been reported to induce remission in, and even cure, patients with lung cancer. However, the side effects of radiotherapy may prove lethal in certain patients. In past decades, the transforming growth factor β1 (TGFB1) signaling pathway has been revealed to serve multiple functions in the control of lung cancer progression and the radiotherapy response. In mammals, this signaling pathway is initiated through activation of the TGFB1 receptor complex, which signals via cytoplasmic SMAD proteins or other downstream signaling pathways. Multiple studies have demonstrated that TGFB1 serves important functions in lung cancer radiotherapy. The present study summarized and reviewed recent progress in elucidating the function of the TGFB1 signaling pathway in predicting radiation pneumonitis, as well as current strategies for targeting the TGFB1 signaling pathway in lung cancer radiotherapy, which may provide potential targets for lung cancer therapy. |
| doi_str_mv | 10.3892/ol.2017.6991 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5661375</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1985954038</sourcerecordid><originalsourceid>FETCH-LOGICAL-c441t-d6d23cebe200100a7c3407ce0c3bbcf4a54fa5e0ce448d25260ea32a60bd16eb3</originalsourceid><addsrcrecordid>eNpdkc1u1DAQgC0EolXpjTOKBAcOZPF_kgtSVfEnrdQLnK2J7WRdZe1gO632tfogPBMOW1aAfbDH8-mTZwahlwRvWNvR92HaUEyajew68gSdk6ajNcEtfXq6N_wMXaZ0i8sSkrStfI7OaEcII504R8OVuQOvbaqcrzLE0WbnxyrvbJUj-DSEuF8fxhju864aQOcQq58PpEpu9DCtuRny7h4Oq2FaSqxXYawiGBeKKMJ8eIGeDTAle_l4XqDvnz5-u_5Sb28-f72-2taac5JrIw1l2vaWYkwwhkYzjhttsWZ9rwcOgg8gSmg5bw0VVGILjILEvSHS9uwCfTh656XfW6OtL1VMao5uD_GgAjj1b8a7nRrDnRJSEtaIInj7KIjhx2JTVnuXtJ0m8DYsSZGu9FBQwWVBX_-H3oYllp6sVCs6wTFrC_XuSOkYUop2OH2GYLXOUIVJrTNU6wwL_urvAk7wn4kV4M0RSDN440xIJ-ZmW-Oyf3t-AYYkpjI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1985954038</pqid></control><display><type>article</type><title>Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy</title><source>Spandidos Publications Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Lu, Zhonghua ; Tang, Yiting ; Luo, Judong ; Zhang, Shuyu ; Zhou, Xifa ; Fu, Lei</creator><creatorcontrib>Lu, Zhonghua ; Tang, Yiting ; Luo, Judong ; Zhang, Shuyu ; Zhou, Xifa ; Fu, Lei</creatorcontrib><description>Lung cancer was demonstrated to be the most lethal type of malignant tumor amongst humans in the global cancer statistics of 2012. As one of the primary treatments, radiotherapy has been reported to induce remission in, and even cure, patients with lung cancer. However, the side effects of radiotherapy may prove lethal in certain patients. In past decades, the transforming growth factor β1 (TGFB1) signaling pathway has been revealed to serve multiple functions in the control of lung cancer progression and the radiotherapy response. In mammals, this signaling pathway is initiated through activation of the TGFB1 receptor complex, which signals via cytoplasmic SMAD proteins or other downstream signaling pathways. Multiple studies have demonstrated that TGFB1 serves important functions in lung cancer radiotherapy. The present study summarized and reviewed recent progress in elucidating the function of the TGFB1 signaling pathway in predicting radiation pneumonitis, as well as current strategies for targeting the TGFB1 signaling pathway in lung cancer radiotherapy, which may provide potential targets for lung cancer therapy.</description><identifier>ISSN: 1792-1074</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2017.6991</identifier><identifier>PMID: 29113195</identifier><language>eng</language><publisher>Greece: D.A. Spandidos</publisher><subject>Apoptosis ; Cancer therapies ; Cell cycle ; Cell growth ; Chemotherapy ; Cytokines ; Drug dosages ; Growth factors ; Kinases ; Ligands ; Lung cancer ; Medical prognosis ; Metastasis ; Plasma ; Proteins ; Radiation therapy ; radiotherapy ; Review ; Rodents ; Signal transduction ; transforming growth factor β1</subject><ispartof>Oncology letters, 2017-11, Vol.14 (5), p.5681-5687</ispartof><rights>Copyright © 2017, Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2017</rights><rights>Copyright © 2017, Spandidos Publications 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c441t-d6d23cebe200100a7c3407ce0c3bbcf4a54fa5e0ce448d25260ea32a60bd16eb3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661375/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661375/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,5555,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29113195$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lu, Zhonghua</creatorcontrib><creatorcontrib>Tang, Yiting</creatorcontrib><creatorcontrib>Luo, Judong</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Zhou, Xifa</creatorcontrib><creatorcontrib>Fu, Lei</creatorcontrib><title>Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy</title><title>Oncology letters</title><addtitle>Oncol Lett</addtitle><description>Lung cancer was demonstrated to be the most lethal type of malignant tumor amongst humans in the global cancer statistics of 2012. As one of the primary treatments, radiotherapy has been reported to induce remission in, and even cure, patients with lung cancer. However, the side effects of radiotherapy may prove lethal in certain patients. In past decades, the transforming growth factor β1 (TGFB1) signaling pathway has been revealed to serve multiple functions in the control of lung cancer progression and the radiotherapy response. In mammals, this signaling pathway is initiated through activation of the TGFB1 receptor complex, which signals via cytoplasmic SMAD proteins or other downstream signaling pathways. Multiple studies have demonstrated that TGFB1 serves important functions in lung cancer radiotherapy. The present study summarized and reviewed recent progress in elucidating the function of the TGFB1 signaling pathway in predicting radiation pneumonitis, as well as current strategies for targeting the TGFB1 signaling pathway in lung cancer radiotherapy, which may provide potential targets for lung cancer therapy.</description><subject>Apoptosis</subject><subject>Cancer therapies</subject><subject>Cell cycle</subject><subject>Cell growth</subject><subject>Chemotherapy</subject><subject>Cytokines</subject><subject>Drug dosages</subject><subject>Growth factors</subject><subject>Kinases</subject><subject>Ligands</subject><subject>Lung cancer</subject><subject>Medical prognosis</subject><subject>Metastasis</subject><subject>Plasma</subject><subject>Proteins</subject><subject>Radiation therapy</subject><subject>radiotherapy</subject><subject>Review</subject><subject>Rodents</subject><subject>Signal transduction</subject><subject>transforming growth factor β1</subject><issn>1792-1074</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNpdkc1u1DAQgC0EolXpjTOKBAcOZPF_kgtSVfEnrdQLnK2J7WRdZe1gO632tfogPBMOW1aAfbDH8-mTZwahlwRvWNvR92HaUEyajew68gSdk6ajNcEtfXq6N_wMXaZ0i8sSkrStfI7OaEcII504R8OVuQOvbaqcrzLE0WbnxyrvbJUj-DSEuF8fxhju864aQOcQq58PpEpu9DCtuRny7h4Oq2FaSqxXYawiGBeKKMJ8eIGeDTAle_l4XqDvnz5-u_5Sb28-f72-2taac5JrIw1l2vaWYkwwhkYzjhttsWZ9rwcOgg8gSmg5bw0VVGILjILEvSHS9uwCfTh656XfW6OtL1VMao5uD_GgAjj1b8a7nRrDnRJSEtaIInj7KIjhx2JTVnuXtJ0m8DYsSZGu9FBQwWVBX_-H3oYllp6sVCs6wTFrC_XuSOkYUop2OH2GYLXOUIVJrTNU6wwL_urvAk7wn4kV4M0RSDN440xIJ-ZmW-Oyf3t-AYYkpjI</recordid><startdate>20171101</startdate><enddate>20171101</enddate><creator>Lu, Zhonghua</creator><creator>Tang, Yiting</creator><creator>Luo, Judong</creator><creator>Zhang, Shuyu</creator><creator>Zhou, Xifa</creator><creator>Fu, Lei</creator><general>D.A. Spandidos</general><general>Spandidos Publications UK Ltd</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20171101</creationdate><title>Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy</title><author>Lu, Zhonghua ; Tang, Yiting ; Luo, Judong ; Zhang, Shuyu ; Zhou, Xifa ; Fu, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c441t-d6d23cebe200100a7c3407ce0c3bbcf4a54fa5e0ce448d25260ea32a60bd16eb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Apoptosis</topic><topic>Cancer therapies</topic><topic>Cell cycle</topic><topic>Cell growth</topic><topic>Chemotherapy</topic><topic>Cytokines</topic><topic>Drug dosages</topic><topic>Growth factors</topic><topic>Kinases</topic><topic>Ligands</topic><topic>Lung cancer</topic><topic>Medical prognosis</topic><topic>Metastasis</topic><topic>Plasma</topic><topic>Proteins</topic><topic>Radiation therapy</topic><topic>radiotherapy</topic><topic>Review</topic><topic>Rodents</topic><topic>Signal transduction</topic><topic>transforming growth factor β1</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Zhonghua</creatorcontrib><creatorcontrib>Tang, Yiting</creatorcontrib><creatorcontrib>Luo, Judong</creatorcontrib><creatorcontrib>Zhang, Shuyu</creatorcontrib><creatorcontrib>Zhou, Xifa</creatorcontrib><creatorcontrib>Fu, Lei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Oncology letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Zhonghua</au><au>Tang, Yiting</au><au>Luo, Judong</au><au>Zhang, Shuyu</au><au>Zhou, Xifa</au><au>Fu, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy</atitle><jtitle>Oncology letters</jtitle><addtitle>Oncol Lett</addtitle><date>2017-11-01</date><risdate>2017</risdate><volume>14</volume><issue>5</issue><spage>5681</spage><epage>5687</epage><pages>5681-5687</pages><issn>1792-1074</issn><eissn>1792-1082</eissn><abstract>Lung cancer was demonstrated to be the most lethal type of malignant tumor amongst humans in the global cancer statistics of 2012. As one of the primary treatments, radiotherapy has been reported to induce remission in, and even cure, patients with lung cancer. However, the side effects of radiotherapy may prove lethal in certain patients. In past decades, the transforming growth factor β1 (TGFB1) signaling pathway has been revealed to serve multiple functions in the control of lung cancer progression and the radiotherapy response. In mammals, this signaling pathway is initiated through activation of the TGFB1 receptor complex, which signals via cytoplasmic SMAD proteins or other downstream signaling pathways. Multiple studies have demonstrated that TGFB1 serves important functions in lung cancer radiotherapy. The present study summarized and reviewed recent progress in elucidating the function of the TGFB1 signaling pathway in predicting radiation pneumonitis, as well as current strategies for targeting the TGFB1 signaling pathway in lung cancer radiotherapy, which may provide potential targets for lung cancer therapy.</abstract><cop>Greece</cop><pub>D.A. Spandidos</pub><pmid>29113195</pmid><doi>10.3892/ol.2017.6991</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1792-1074 |
| ispartof | Oncology letters, 2017-11, Vol.14 (5), p.5681-5687 |
| issn | 1792-1074 1792-1082 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5661375 |
| source | Spandidos Publications Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central |
| subjects | Apoptosis Cancer therapies Cell cycle Cell growth Chemotherapy Cytokines Drug dosages Growth factors Kinases Ligands Lung cancer Medical prognosis Metastasis Plasma Proteins Radiation therapy radiotherapy Review Rodents Signal transduction transforming growth factor β1 |
| title | Advances in targeting the transforming growth factor β1 signaling pathway in lung cancer radiotherapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A55%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20targeting%20the%20transforming%20growth%20factor%20%CE%B21%20signaling%20pathway%20in%20lung%20cancer%20radiotherapy&rft.jtitle=Oncology%20letters&rft.au=Lu,%20Zhonghua&rft.date=2017-11-01&rft.volume=14&rft.issue=5&rft.spage=5681&rft.epage=5687&rft.pages=5681-5687&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2017.6991&rft_dat=%3Cproquest_pubme%3E1985954038%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1985954038&rft_id=info:pmid/29113195&rfr_iscdi=true |